Jump to main content
Jump to site search

Issue 9, 2019
Previous Article Next Article

The dipeptidyl peptidase-4 inhibitory effect of flavonoids is hindered in protein rich environments

Author affiliations

Abstract

Dipeptidyl peptidase-4 (DPP-4) inhibitors present a unique approach for the management of type 2 diabetes (T2D). In the present study, the inhibition of DPP-4 was evaluated for a large panel of flavonoids, important components of the human diet, using in vitro and ex vivo models. The activity of the isolated enzyme was assayed in vitro. Subsequently, the most active flavonoids were tested ex vivo in human whole blood and plasma. In this study, contrary to the in vitro fluorometric tests, flavonoids did not show inhibitory activity against DPP-4. Due to the discrepancy in the results between the in vitro and ex vivo approaches, plasma protein binding values were determined, presenting values from 43.9 to 100.0%. This work provides a new insight into the inhibitory activity for DPP-4, based on the flavonoid scaffold. Additionally, the obtained results showed that the inhibitory effect of flavonoids against DPP-4 was hindered in protein rich environments, like that occurring in blood, and indicated the need for experimental refinement in drug discovery for blood targets.

Graphical abstract: The dipeptidyl peptidase-4 inhibitory effect of flavonoids is hindered in protein rich environments

Back to tab navigation

Supplementary files

Article information


Submitted
08 Apr 2019
Accepted
18 Jul 2019
First published
23 Aug 2019

Food Funct., 2019,10, 5718-5731
Article type
Paper

The dipeptidyl peptidase-4 inhibitory effect of flavonoids is hindered in protein rich environments

C. Proença, M. Freitas, D. Ribeiro, S. M. Tomé, A. N. Araújo, A. M. S. Silva, P. A. Fernandes and E. Fernandes, Food Funct., 2019, 10, 5718
DOI: 10.1039/C9FO00722A

Social activity

Search articles by author

Spotlight

Advertisements